Additionally, genetic ablating iNOS in a very similar oncogenic Kras-driven mouse lung cancer model phenocopies the effect of L-NAME, namely loss of iNOS led to a reduction in lung tumorigenesis [8]. Here, KRAS is linked to lung carcinoma.